WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5301 Infant (under 12 months) mortality rate: 342
GDP / capita (US$): 1'1951 Child (under 5 years) mortality rate: 472

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 5'228  5'110  4'999  4'892  4'790  3'535  3'139  2'384 
Births 175  175  175  174  174  131  132  111 
Surviving infants 168  167  167  166  165  122  119  98 
Pop. less than 5 years 815  809  805  800  793  560  576  440 
Pop. less than 15 years 2'237  2'187  2'136  2'085  2'035  1'633  1'474  1'098 
Female 15-49 years 1'269  1'242  1'218  1'196  1'176  809  722  558 

Number of reported cases

(Click for retrospective incidence data for Eritrea)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  198  127  45  194  48  789 
Mumps
ChartChart
  2'350  3'825  2'028 
Pertussis
ChartChart
  208  91  152 
Polio*
ChartChart
 
Rubella
ChartChart
  16  109  19  18  354  39 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  19  17  11 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Eritrea)
Vaccine year result method % card seen                                                
BCG 2012  100  EPI   94  97  97  97  97  97  61 
DTP1 2012  100  EPI   94  98  97  97  97  97  59 
DTP3 2012  99  EPI   94  95  94  94  94  94  52 
DTP4         
IPV1          98 
HepB_BD         
HepB3 2012  99  EPI   94  95  94  94  94  94 
Hib3 2012  99  EPI   94  95  94  94  94  94 
JapEnc         
MCV1          85  90  75  77  95  50 
MCV2          75 
PCV1         
PCV3         
Pol3 2012  99  EPI   94  95  94  94  94  94  52 
Rota1          98  77 
RotaC          96  75 
Rubella1         
TT2plus 2012  97  EPI   94  65  35  94  35  35  25 
PAB         
VAD1          95  95  95  95  95 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Eritrea)
BCG
ChartChart
  97  97  97  98  89 
DTP1
ChartChart
  97  97  97  99  88 
DTP3
ChartChart
  94  94  94  96  81 
HepB3
ChartChart
  94  94  94  96 
HepB_BD
ChartChart
 
Hib3
ChartChart
  94  94  94  99 
MCV1
ChartChart
  96  96  98  99  76 
MCV2
ChartChart
 
PAB
ChartChart
  94  94  94  93  80 
PCV3
ChartChart
 
Pol3
ChartChart
  94  94  94  96  82 
RotaC
ChartChart
  25 

Number of districts in the country 58  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 40
From 80 to 89% 10
From 50 to 79% 41
Less than 50% 9
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 years; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 58  58  58  58  58 

System performance

Total Nº districts in country number 58  58  58  58  58 
Nº districts with DTP3 coverage >=80% number 21  23  28  32 
% of districts with DTP3 coverage >=80% From 0 to 100% 36  40  48  55  12  17  17 
Nº districts with measles (MCV1) coverage >=95% number 13  16  17  12 
% of districts with MCV1 coverage >=95% From 0 to 100% 22  28  29  21 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 22  30  26  30  15     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.